---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-24-000158"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:14:21.657992+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# BioRestorative Therapies schedules Q2 2024 earnings release and call for Aug 13

## Summary
- Financial results for Q2 2024 will be released after market close on Tuesday, August 13, 2024.
- Management will host a conference call following the release to review results and provide a business update.
- Press release announcing the schedule was issued on August 6, 2024.
- No financial figures or guidance were provided in this filing.

## SEC filing metadata
- accession: 0001021771-24-000158
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000158/0001021771-24-000158-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000158/brt8624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-24-000158
- JSON: https://secwatch.observer/filing/0001021771-24-000158.json
- Plain text: https://secwatch.observer/filing/0001021771-24-000158.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.